The artificial heart. Costs, risks, and benefits--an update

Area of Science:

• Biomedical Engineering
• Health Economics
• Cardiology

Background:

• End-stage heart disease affects a significant population, with many potentially eligible for artificial heart devices.
• Current artificial heart protocols limit eligible candidates due to informed consent requirements.
• Artificial heart technology presents a substantial advancement in treating advanced cardiac conditions.

Purpose of the Study:

• To assess the potential costs and benefits of artificial heart implantation.
• To compare the artificial heart's impact on life expectancy and resource allocation with existing medical interventions.
• To highlight the need for comprehensive data collection on artificial heart performance and associated costs.

Main Methods:

• Estimating the number of potential artificial heart candidates annually.
• Calculating projected costs for the artificial heart, including surgery, device, and ongoing care.
• Analyzing survival rates and life expectancy increases associated with the artificial heart.
• Comparing artificial heart therapy with heart transplantation and other life-extending programs.

Main Results:

• Approximately 32,500 individuals annually are potential candidates, limited to 12,000 by current consent protocols.
• Initial artificial heart costs range from $100,000 to $300,000 per patient.
• Projected fifth-year program costs range from $1.3 billion to $3.8 billion.
• Artificial heart recipients may gain an average of half a year in life expectancy.

Conclusions:

• Artificial heart implantation could significantly increase healthcare costs for end-stage heart disease.
• Careful economic and social assessment is crucial for this expensive innovation.
• Data collection on artificial heart performance and costs is vital for future policy and reimbursement decisions.